Clinical Trials in Phoenix

Showing 10521-10540 of 12,606 trials

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

NCT01731652

This is a Phase II pilot study to explore the effect of intravesical TMX-101 in patients with CIS bladder cancer, as assessed by histology and cytology after TMX-101 treatment.

Carcinoma in SituNon Muscle Invasive Bladder Cancer

Telormedix SA12 participantsStarted Feb 2013

Phoenix, Arizona, United States • Denver, Colorado, United States • Bala-Cynwyd, Pennsylvania, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

NCT01731730

The objectives of this proof of concept study are to evaluate the safety and preventive analgesic efficacy of a single preoperative intrathecal administration of AYX1 Injection in patients undergoing unilateral total knee arthroplasty.

Postsurgical Pain

Adynxx, Inc.102 participantsStarted Jan 2013

Sheffield, Alabama, United States • Phoenix, Arizona, United States • Boynton Beach, Florida, United States +4 more locations

COMPLETEDPhase 3< 1 mile

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

NCT00420212

To determine if treatment with BG00012 can decrease the number of MS relapses during a certain time period. To determine if, over time, BG00012 treatment can decrease the number of certain types of brain lesions commonly seen in MS patients and slow down the time it takes for the disease to get worse. The purpose of this study is also to determine the safety of BG00012 and how well it is tolerated. Another goal is to see what effect BG00012 may have on tests and evaluations used to assess MS.

Relapsing-Remitting Multiple Sclerosis

Biogen1,234 participantsStarted Jan 2007

Gilbert, Arizona, United States • Phoenix, Arizona, United States • San Francisco, California, United States +156 more locations

Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer

Study to Evaluate Safety/Efficacy of a Single Pre-Op Dose of AYX1 Injection to Treat Pain After Knee Replacement Surgery

Efficacy and Safety of Oral BG00012 in Relapsing-Remitting Multiple Sclerosis

Find Trials by Condition in Phoenix

NAVISTAR® THERMOCOOL® SF Catheter: Observational Study

Outcomes in Rotator Cuff Repair Using Graft Reinforcement

Efficacy and Safety Study of Oral BG00012 With Active Reference in Relapsing-Remitting Multiple Sclerosis

Aneurysm Study of Pipeline in an Observational Registry

Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Maximal Stimulation Tests of Subjects With Type 2 Diabetes Mellitus

Study to Examine Safety, Tolerability and Effect on Body Weight of Subcutaneous AC2307 in Obese or Overweight Subjects

Long Term Safety of Tobramycin Inhalation Powder in Patients With Cystic Fibrosis

A Study of TMC435 in Combination With PSI-7977 (GS7977) in Chronic Hepatitis C Genotype 1-Infected Prior Null Responders To Peginterferon/Ribavirin Therapy or HCV Treatment-Naive Patients

Study of Oasis Ultra in Diabetic Foot Ulcers

A Postmarket Randomized Study of the Treatment of Superficial Partial-Thickness Burns Using Two Dressings

Trastuzumab (Herceptin), Paclitaxel, Carboplatin and Gemcitabine in Advanced Urothelial Cancer

Multiple Dose-parallel-group Study of AMA0076 in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension

Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Zemaira in Subjects With Emphysema Due to Alpha1-Proteinase Inhibitor Deficiency

Safety and Efficacy Study of the Sorin 3D Annuloplasty Ring For Mitral Repair

Post-Partum Immunization With Live Attenuated Influenza Vaccine (LAIV) or Trivalent Influenza Vaccine (TIV) in Post-Partum Breast Feeding Women